AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹996 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr | ₹839 Cr |
What is the latest Total Current Liabilities ratio of AJANTA PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹996 Cr |
Mar2024 | ₹895 Cr |
Mar2023 | ₹1,139 Cr |
Mar2022 | ₹647 Cr |
Mar2021 | ₹839 Cr |
How is Total Current Liabilities of AJANTA PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹996 Cr | 11.27 | |
Mar2024 | ₹895 Cr | -21.42 | |
Mar2023 | ₹1,139 Cr | 75.98 | |
Mar2022 | ₹647 Cr | -22.82 | |
Mar2021 | ₹839 Cr | - |
Compare Total Current Liabilities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹31,718.4 Cr | -0.2% | -5% | -19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -0.2% |
-5% |
-19.2% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses